| Patent Number |
Title Of Patent |
Date Issued |
| 6468536 |
Use of proteins as anti-diabetes agents |
October 22, 2002 |
| The use of proteins extracted with perchloric acid from animal organs for the preparation of medicaments active against autoimmune diseases, in particular with activity against atherosclerosis, arthritis, multiple sclerosis, and diabetes. |
| 6255283 |
Use of proteins extractable from animal organs for the preparation of medicaments for the treatm |
July 3, 2001 |
| Proteins extractable with perchloric acid from mammal liver, in particular from goat liver, are capable of lowering blood levels of Tumor Necrosis Factor (TNF) and can be used for the treatment of multiple sclerosis, rheumatoid arthritis, septic shock and other pathologies characterized |
| 6207200 |
Use of proteins as anti-retroviral agents |
March 27, 2001 |
| The present invention relates to the discovery that a protein, having a molecular weight of about 14 Kd, extracted with perchloric acid from animal organs such as goat liver, has anti-retroviral activity, and may be used in the treatment of Human Immunodeficiency Virus. |
| 6107474 |
Nucleotide sequence encoding a 14 kDa protein from goat liver |
August 22, 2000 |
| A complete cDNA sequence (SEQ ID NO: 1) is described, which codes for a 14 kDa protein (SEQ ID NO: 2) obtainable from goat liver. This protein shows marked anti-neoplastic activity both in vitro and in vivo. The serum of animals immunized with this protein displays cytotoxic activity aga |
| 5824640 |
Substances of polypeptide nature useful in human therapy |
October 20, 1998 |
| Substances of polypeptide nature are obtainable by extraction with HClO.sub.4 and 3M KCl from animal tissue homogenates. The substances have the characteristics of (a) molecular weights ranging from 10,000 to 50,000 daltons (by polyacrylamide gel electrophoresis); (b) are capable of |
| 5792744 |
Proteins from mammalian liver |
August 11, 1998 |
| The present invention relates to proteins that may be extracted from mammalian livers. The proteins of the invention have a molecular weight of 14 Kda as measured by SDS-PAGE electrophoresis and comprise the sequence identified in the application as Sequence No. 1. The proteins of the |
